Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 15

1.

Brief assessment of motor function: content validity and reliability of the oral motor scales.

Sonies BC, Cintas HL, Parks R, Miller J, Caggiano C, Gottshall SG, Gerber L.

Am J Phys Med Rehabil. 2009 Jun;88(6):464-72. doi: 10.1097/PHM.0b013e3181a5abad.

PMID:
19454854
2.

Pharmacology of 2-[4-(4-chloro-2-fluorophenoxy)phenyl]-pyrimidine-4-carboxamide: a potent, broad-spectrum state-dependent sodium channel blocker for treating pain states.

Ilyin VI, Pomonis JD, Whiteside GT, Harrison JE, Pearson MS, Mark L, Turchin PI, Gottshall S, Carter RB, Nguyen P, Hogenkamp DJ, Olanrewaju S, Benjamin E, Woodward RM.

J Pharmacol Exp Ther. 2006 Sep;318(3):1083-93. Epub 2006 May 25.

3.

A role for cannabinoid receptors, but not endogenous opioids, in the antinociceptive activity of the CB2-selective agonist, GW405833.

Whiteside GT, Gottshall SL, Boulet JM, Chaffer SM, Harrison JE, Pearson MS, Turchin PI, Mark L, Garrison AE, Valenzano KJ.

Eur J Pharmacol. 2005 Dec 28;528(1-3):65-72. Epub 2005 Nov 28.

PMID:
16316650
4.

Pharmacological and pharmacokinetic characterization of the cannabinoid receptor 2 agonist, GW405833, utilizing rodent models of acute and chronic pain, anxiety, ataxia and catalepsy.

Valenzano KJ, Tafesse L, Lee G, Harrison JE, Boulet JM, Gottshall SL, Mark L, Pearson MS, Miller W, Shan S, Rabadi L, Rotshteyn Y, Chaffer SM, Turchin PI, Elsemore DA, Toth M, Koetzner L, Whiteside GT.

Neuropharmacology. 2005 Apr;48(5):658-72.

PMID:
15814101
5.

Development and pharmacological characterization of a rat model of osteoarthritis pain.

Pomonis JD, Boulet JM, Gottshall SL, Phillips S, Sellers R, Bunton T, Walker K.

Pain. 2005 Apr;114(3):339-46. Epub 2004 Dec 19.

PMID:
15777859
6.

Synthesis and evaluation of novel peripherally restricted kappa-opioid receptor agonists.

Kumar V, Guo D, Cassel JA, Daubert JD, Dehaven RN, Dehaven-Hudkins DL, Gauntner EK, Gottshall SL, Greiner SL, Koblish M, Little PJ, Mansson E, Maycock AL.

Bioorg Med Chem Lett. 2005 Feb 15;15(4):1091-5.

PMID:
15686919
7.

Azepinone as a conformational constraint in the design of kappa-opioid receptor agonists.

Tuthill PA, Seida PR, Barker W, Cassel JA, Belanger S, DeHaven RN, Koblish M, Gottshall SL, Little PJ, DeHaven-Hudkins DL, Dolle RE.

Bioorg Med Chem Lett. 2004 Nov 15;14(22):5693-7.

PMID:
15482950
8.

Pharmacological characterisation of a rat model of incisional pain.

Whiteside GT, Harrison J, Boulet J, Mark L, Pearson M, Gottshall S, Walker K.

Br J Pharmacol. 2004 Jan;141(1):85-91. Epub 2003 Nov 3.

9.

Arylacetamides as peripherally restricted kappa opioid receptor agonists.

Kumar V, Marella MA, Cortes-Burgos L, Chang AC, Cassel JA, Daubert JD, DeHaven RN, DeHaven-Hudkins DL, Gottshall SL, Mansson E, Maycock AL.

Bioorg Med Chem Lett. 2000 Nov 20;10(22):2567-70.

PMID:
11086731
11.

Effect of induced pyometra on luteal lifespan and uterine fluid concentrations of prostaglandins and interferons in cows.

Davidson JA, Wright DJ, Archbald LF, Klapstein E, Gottshall SL, Hansen PJ.

Theriogenology. 1996 Jan 15;45(2):459-70.

PMID:
16727809
12.

Enhancement of mitogen-induced lymphocyte proliferation in sheep.

Gottshall SL, Hansen PJ.

Zentralbl Veterinarmed B. 1994 Oct;41(7-8):541-7.

PMID:
7701867
13.
14.

Succinylcholine-pantothenyl alcohol. A reappraisal.

Smith RM Jr, Gottshall SC, Young JA.

Anesth Analg. 1969 Mar-Apr;48(2):205-8. No abstract available.

PMID:
5813067
15.

Use of aerosol isoproterenol in an anesthesia circuit.

Fresoli RP, Smith RM Jr, Young JA, Gottshall SC.

Anesth Analg. 1968 Mar-Apr;47(2):127-32. No abstract available.

PMID:
5689227

Supplemental Content

Loading ...
Support Center